Risk of Autoimmune Rheumatic Diseases in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea
Soonwook Kwon(Inha University Hospital), Ju‐Hong Min(Samsung Medical Center), Yeon Hak Chung(Samsung Medical Center), Kyungdo Han(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Eun Bin Cho(Changwon National University), Jin‐Hyung Jung(Samsung (South Korea)), Junhee Park(Samsung Medical Center), Hyungjin Kim(Samsung Medical Center), Dong Wook Shin(Samsung (South Korea)), Yeonghee Eun(Kangbuk Samsung Hospital)
Cited by 3
Related Papers
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82
Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
|Journal of Korean Medical Science|2012|58